TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23932743

Group type: EXPERIMENTAL
Intervention: Pharmacologic pain management education with distraction (experimental group)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Pharmacologic pain management education (control group)
Number of subjects: 93
Study: 23769603

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Conventional surgery (CS)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy (UGFS)
Number of subjects: 240

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 240
Study: 20492042

Group type: EXPERIMENTAL
Intervention: Music listening group
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Headphone group
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137
Study: 18625626

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (phylloquinone)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (phylloquinone) in participants with insufficient vitamin K at baseline
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 15715187

Group type: EXPERIMENTAL
Intervention: Prednisolone (30mg per day for 7 days)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Budesonide (800 microg twice daily for 4 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 29

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 29
Study: 11966502

Group type: EXPERIMENTAL
Intervention: 28 tablets (42 g) of sodium phosphate
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 32 tablets (48 g) of sodium phosphate
Number of subjects: 100
Study: 9930706

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization (TMR)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Continued medical management
Number of subjects: 198
Study: 7503931

Group type: EXPERIMENTAL
Intervention: Wrigley's Spearmint chewing-gum
Number of subjects: 12

Group type: COMPARATOR
Intervention: gum-base
Number of subjects: 12
Study: 2405462

Group type: EXPERIMENTAL
Intervention: Betadine solution standardized
Number of subjects: 0

Group type: COMPARATOR
Intervention: Merfen tincture
Number of subjects: 0
Study: 7000234

Group type: EXPERIMENTAL
Intervention: Continuous nylon sutures
Number of subjects: 105

Group type: COMPARATOR
Intervention: Interrupted nylon sutures
Number of subjects: 105
Study: 31826369

Group type: EXPERIMENTAL
Intervention: 12.5% oral carbohydrate drink
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pure water (control)
Number of subjects: 70
Study: 25952614

Group type: EXPERIMENTAL
Intervention: Laparoscopic adrenalectomy (LA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Open adrenalectomy
Number of subjects: 51
Study: 23786487

Group type: EXPERIMENTAL
Intervention: Compression stockings made with thread reflecting long-wave infrared (LWIR) radiation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Compression stockings without thread reflecting long-wave infrared (LWIR) radiation
Number of subjects: 30
Study: 21411615

Group type: EXPERIMENTAL
Intervention: Cranberry juice (double-strength, 54% juice, 835 mg total polyphenols, 94 mg anthocyanins, 480 mL/d for 4 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo beverage (480 mL/d for 4 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Cranberry juice (single 480-mL portion)
Number of subjects: 44
Study: 19451330

Group type: EXPERIMENTAL
Intervention: Progesterone‐incorporated intrauterine system (IUS; Mirena)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Copper intrauterine contraceptive device (IUCD)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Copper IUCD
Number of subjects: 172
Study: 16617567

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 142

Group type: COMPARATOR
Intervention: Dose-intensified chemotherapy
Number of subjects: 142
Study: 15598474

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 11392270

Group type: EXPERIMENTAL
Intervention: Drifting sinusoidal grating background stimulation during computer game training for 10 days (2 sessions of 20 minutes daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo group with neutral background during computer game training for 10 days (2 sessions of 20 minutes daily)
Number of subjects: 14
Study: 9271751

Group type: EXPERIMENTAL
Intervention: Combination of blood conservation strategies; specific interventions not detailed.
Number of subjects: 0
Study: 8303896

Group type: EXPERIMENTAL
Intervention: Nurse counseling message
Number of subjects: 57

Group type: COMPARATOR
Intervention: Videotape or booklet on smoking cessation
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual care at the clinic
Number of subjects: 57
Study: 3661275

Group type: EXPERIMENTAL
Intervention: Pipeline methodology with confidentiality but not anonymity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pipeline methodology with anonymity assured
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group) for alcohol disclosure
Number of subjects: 0
Study: 29650060

Group type: EXPERIMENTAL
Intervention: Pre-treatment gastrostomy tube feeding
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral feeding plus as-required nasogastric tube feeding
Number of subjects: 75
Study: 28448457

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2800 IU daily for eight weeks)
Number of subjects: 197
Study: 25651444

Group type: EXPERIMENTAL
Intervention: Higher BMI at midlife
Number of subjects: 2817

Group type: EXPERIMENTAL
Intervention: Larger WC at midlife
Number of subjects: 2817

Group type: COMPARATOR
Intervention: Obese participants in midlife
Number of subjects: 2817

Group type: EXPERIMENTAL
Intervention: Midlife dietary patterns adjustment
Number of subjects: 2817

Group type: EXPERIMENTAL
Intervention: No relationships observed
Number of subjects: 2817
Study: 24125113

Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 3252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3252
Study: 20869201

Group type: EXPERIMENTAL
Intervention: Rope jumping exercise (controlled with RPE values ranging from 11 to 15)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 0
Study: 19099850

Group type: EXPERIMENTAL
Intervention: Pulmonary surfactant (PS) treatment in preterm infants (n=28)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Pulmonary surfactant (PS) treatment in term and late-preterm infants (n=8)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) in preterm infants
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV) in term and late-preterm infants
Number of subjects: 177

Group type: COMPARATOR
Intervention: Comparison of OI between preterm and term/late-preterm infants
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Incidence of pneumothorax in preterm infants
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Incidence of pneumothorax in term and late-preterm infants
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Incidence of persistent pulmonary hypertension of the newborn (PPHN) in preterm infants
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Incidence of persistent pulmonary hypertension of the newborn (PPHN) in term and late-preterm infants
Number of subjects: 177
Study: 16313122

Group type: EXPERIMENTAL
Intervention: Qingxue Granules (QX)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Enalapril (WM group)
Number of subjects: 20
Study: 12451480

Group type: EXPERIMENTAL
Intervention: Rubitecan 1.5 mg/m(2) per day orally
Number of subjects: 14
Study: 10519494

Group type: EXPERIMENTAL
Intervention: Hypotensive mean arterial blood pressure range of 45‐55 mmHg
Number of subjects: 235

Group type: COMPARATOR
Intervention: Less hypotensive mean arterial blood pressure range of 55‐70 mmHg
Number of subjects: 235
Study: 8813496

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (100 mg per day initially, dosage reduction every 3 days; n = 15)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Thiamine (100 mg per day; n = 33)
Number of subjects: 48
Study: 1827103

Group type: EXPERIMENTAL
Intervention: Clarithromycin 250 mg orally (500 mg for lung tissue), administered every 12 h for three days.
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Roxithromycin 150 mg orally, administered every 12 h for three days.
Number of subjects: 174
Study: 7094857

Group type: EXPERIMENTAL
Intervention: Extra maternal-infant contact during the first postpartum hour
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine contact
Number of subjects: 60
Study: 31399091

Group type: EXPERIMENTAL
Intervention: CHF6001 800 μg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: CHF6001 1600 μg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 29917125

Group type: EXPERIMENTAL
Intervention: Congruent Pictorial Health Warning Labels (PWLs)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Incongruent Pictorial Health Warning Labels (PWLs)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Both Congruent and Incongruent PWLs
Number of subjects: 320
Study: 29141843

Group type: EXPERIMENTAL
Intervention: STABLE‐SR
Number of subjects: 229

Group type: COMPARATOR
Intervention: STEPWISE
Number of subjects: 229
Study: 26712982

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg capsule 1 hour before surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 200
Study: 23782920

Group type: EXPERIMENTAL
Intervention: Fine CAPs exposure
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Coarse CAPs exposure
Number of subjects: 15

Group type: COMPARATOR
Intervention: HEPA-filtered medical air (control)
Number of subjects: 15
Study: 21943111

Group type: EXPERIMENTAL
Intervention: Restrictive fluid strategy (4 ml/kg/hour of Ringer's lactate solution)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional fluid strategy (12 ml/kg/hour of Ringer's lactate solution)
Number of subjects: 88
Study: 18588512

Group type: EXPERIMENTAL
Intervention: ACEi (angiotensin‐converting enzyme inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ARBs (angiotensin II receptor blockers)
Number of subjects: 0
Study: 16515395

Group type: EXPERIMENTAL
Intervention: HTT-blocking antidepressants (SSRIs, TCAs)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Mirtazapine
Number of subjects: 109
Study: 15260082

Group type: EXPERIMENTAL
Intervention: Ketamine (0.3 mg/kg/hr) and Propofol (initial rate of 10 mg/kg/hr)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline) and Propofol (initial rate of 10 mg/kg/hr)
Number of subjects: 20
Study: 11729708

Group type: EXPERIMENTAL
Intervention: Infloran Berna (10^9 Lactobacillus acidophilus and 10^9 Bifidobacterium infantis, one capsule tid for 4 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (parenteral rehydration only)
Number of subjects: 100
Study: 9228366

Group type: EXPERIMENTAL
Intervention: NIVS with a nasal ventilatory support system (BiPAP) during 1 h
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no NIVS)
Number of subjects: 19
Study: 8219661

Group type: EXPERIMENTAL
Intervention: n-3 fatty acid based lipid emulsion (100 ml/day with 2.1 g eicosapentaenoic (EPA) and 21 g docosahexaenoic acid (DHA))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional n-6 lipid emulsion (EPA + DHA < 0.1 g/100 ml)
Number of subjects: 20
Study: 2887189

Group type: EXPERIMENTAL
Intervention: epanolol 400 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: atenolol 100 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: epanolol 200 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: epanolol 400 mg and atenolol 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: pharmacological and non-pharmacological interventions
Number of subjects: 8
Study: 31586176

Group type: EXPERIMENTAL
Intervention: Trial 1A (common procedure)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Trial 1B
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Trial 2C
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Trial 3A
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Trial 3D
Number of subjects: 411

Group type: COMPARATOR
Intervention: Trial 2 (Arm C/D)
Number of subjects: 411
Study: 30406067

Group type: EXPERIMENTAL
Intervention: Meditative movement (MM) training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health education (HE) videos
Number of subjects: 0
Study: 27072143

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Immediate release morphine (IRM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (OTFC and IRM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: OTFC
Number of subjects: 60

Group type: COMPARATOR
Intervention: IRM
Number of subjects: 60
Study: 24939433

Group type: EXPERIMENTAL
Intervention: 100 mg isoflavones/day (supplements)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 48 mg isoflavones/day (soy foods)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Doubling isoflavone intake
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Inter-individual variation
Number of subjects: 103
Study: 23933107

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 sessions
Number of subjects: 46

Group type: COMPARATOR
Intervention: Acceptance and Commitment Therapy (ACT) for 12 sessions
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Overall predictor of treatment outcome
Number of subjects: 46
Study: 20505108

Group type: EXPERIMENTAL
Intervention: Overlapping mazes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-overlapping mazes
Number of subjects: 0
Study: 18840817

Group type: COMPARATOR
Intervention: Biomarker assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rigorous standards for biomarker evaluation
Number of subjects: 0
Study: 16619561

Group type: COMPARATOR
Intervention: sEGFR levels below 45 ng/mL
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: sEGFR levels below 45 ng/mL and elevated serum HER‐2/neu ECD (>15 ng/mL)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: sEGFR levels below 45 ng/mL in estrogen receptor-positive tumors
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: sEGFR levels below 45 ng/mL in estrogen receptor-positive tumors with elevated HER‐2/neu ECD
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Chemotherapy treatment
Number of subjects: 101
Study: 12764215

Group type: EXPERIMENTAL
Intervention: Group psychotherapy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Not applicable (no control group mentioned)
Number of subjects: 59
Study: 10888102

Group type: EXPERIMENTAL
Intervention: Bioflo pericardial bioprosthesis
Number of subjects: 170

Group type: COMPARATOR
Intervention: Carpentier‐Edwards (CE) supra‐annular porcine bioprosthesis
Number of subjects: 170
Study: 8863088

Group type: EXPERIMENTAL
Intervention: Chronic illness (females)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (females)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Chronic illness (males)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (males)
Number of subjects: 162
Study: 2017337

Group type: EXPERIMENTAL
Intervention: Regimen A: vancomycin 250 mg, tobramycin 75 mg, colistin 1 million IU, nystatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen B: vancomycin 125 mg, tobramycin 75 mg, colistin 1 million IU, nystatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regimen C: colistin 1 million IU, nystatin
Number of subjects: 0
Study: 618711

Group type: EXPERIMENTAL
Intervention: Stroma-free hemoglobin (SFH) infusion (250 ml administered slowly intravenously)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stroma-free hemoglobin (SFH) infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Serum albumin (250 ml administered to control group)
Number of subjects: 10
Study: 31386219

Group type: EXPERIMENTAL
Intervention: siponimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 28765029

Group type: EXPERIMENTAL
Intervention: 1-stage surgery (combined cervical and thoracic decompression via a single posterior incision)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2-stage surgery (sequential cervical and thoracic decompressions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both surgical approaches (combined and staged)
Number of subjects: 30
Study: 25840644

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Non-diabetic patients
Number of subjects: 207
Study: 23934185

Group type: EXPERIMENTAL
Intervention: Classic tonsillectomy with bipolar cauterization
Number of subjects: 100

Group type: COMPARATOR
Intervention: Harmonic scalpel tonsillectomy
Number of subjects: 100
Study: 21563715

Group type: EXPERIMENTAL
Intervention: Parental education, home evaluation, and lead remediation (intervention group)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Standard lead education (control group)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Combined intervention groups (parental education, home evaluation, and lead remediation)
Number of subjects: 314
Study: 19306033

Group type: EXPERIMENTAL
Intervention: Guar gum beverage
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Oat beta‐glucan beverage
Number of subjects: 19

Group type: COMPARATOR
Intervention: Beverage without fibre
Number of subjects: 19
Study: 16685611

Group type: EXPERIMENTAL
Intervention: Pplateau respiratory pressures
Number of subjects: 34
Study: 16296399

Group type: EXPERIMENTAL
Intervention: Microalgae oil (0.94 g DHA/d)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 104
Study: 14723482

Group type: EXPERIMENTAL
Intervention: MMR vaccine administered at 9-10 months
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: MMR vaccine administered at 15-18 months
Number of subjects: 240
Study: 9469983

Group type: EXPERIMENTAL
Intervention: Potato + 100 g butter
Number of subjects: 12

Group type: COMPARATOR
Intervention: Potato alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Potato + 40 g olive oil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Potato + 50 g butter
Number of subjects: 12

Group type: COMPARATOR
Intervention: Potato + 80 g olive oil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All meals
Number of subjects: 12
Study: 7893263

Group type: EXPERIMENTAL
Intervention: 5 mg/kg vitamin B6 (pyridoxine hydrochloride)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2516308

Group type: EXPERIMENTAL
Intervention: Metronidazole (6 g total, intraoral application six times)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional irradiation method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dynamic irradiation method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dynamic irradiation method with Metronidazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Irradiation twice a day
Number of subjects: 0
Study: 645948

Group type: EXPERIMENTAL
Intervention: Lithium response scale for women in group A
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Lithium response scale for males in group A
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Cross-validation of scales in group B
Number of subjects: 53
Study: 29107662

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28397104

Group type: EXPERIMENTAL
Intervention: Omeprazole (OME) 40 mg administered postoperatively
Number of subjects: 20

Group type: COMPARATOR
Intervention: Preoperative condition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Postoperative condition (6 months after surgery)
Number of subjects: 20
Study: 26087791

Group type: EXPERIMENTAL
Intervention: Forward-viewing linear endoscopic ultrasound (FV-EUS)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard oblique-viewing endoscopic ultrasound (OV-EUS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: FV-EUS-guided fine-needle aspiration (FNA)
Number of subjects: 51
Study: 23843495

Group type: EXPERIMENTAL
Intervention: G‐CHOP (obinutuzumab plus cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: G‐FC (obinutuzumab plus fludarabine and cyclophosphamide)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: G‐CHOP
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: G‐FC
Number of subjects: 56
Study: 19506868

Group type: EXPERIMENTAL
Intervention: Interlocking nailing
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dynamic compression plating
Number of subjects: 36
Study: 18991471

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline 100 mL
Number of subjects: 75
Study: 15845796

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine at doses of 0.05, 0.10, or 0.20 mmol/kg
Number of subjects: 95

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine at a dose of 0.10 mmol/kg
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine-enhanced MR imaging
Number of subjects: 95
Study: 12851058

Group type: EXPERIMENTAL
Intervention: Symbolic dynamics analysis of OKN signals in patients suffering from vertigo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Symbolic dynamics analysis of OKN signals in healthy subjects
Number of subjects: 20
Study: 10596916

Group type: EXPERIMENTAL
Intervention: TM-ILP (TNFalpha and melphalan)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: TIM-ILP (TNFalpha, melphalan, and IFNgamma)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Historical control (M-ILP with melphalan alone)
Number of subjects: 64